A Retrospective Cohort Study of Multiple Immune-Related Adverse Events and Clinical Outcomes Among Patients With Cancer Receiving Immune Checkpoint Inhibitors
Background and Objectives Immune checkpoint inhibitors (ICIs) are effective in various types of cancer and cause immune-related adverse events (irAEs). The occurrence of irAEs is associated with improved survival outcome. We investigated the association between the occurrence of irAEs and overall su...
| Main Authors: | , , , , , , , |
|---|---|
| 格式: | Article |
| 語言: | English |
| 出版: |
SAGE Publishing
2022-09-01
|
| 叢編: | Cancer Control |
| 在線閱讀: | https://doi.org/10.1177/10732748221130576 |